0001209191-22-036803.txt : 20220614
0001209191-22-036803.hdr.sgml : 20220614
20220614190344
ACCESSION NUMBER: 0001209191-22-036803
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220614
DATE AS OF CHANGE: 20220614
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Greenwood Luba
CENTRAL INDEX KEY: 0001853815
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39692
FILM NUMBER: 221016207
MAIL ADDRESS:
STREET 1: C/O BROOKLYN IMMUNOTHERAPEUTICS LLC
STREET 2: 140 58TH STREET, BUILDING A, SUITE 2100
CITY: BROOKLYN
STATE: NY
ZIP: 11220
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IN8BIO, INC.
CENTRAL INDEX KEY: 0001740279
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 825462585
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
BUSINESS PHONE: (646) 600-6438
MAIL ADDRESS:
STREET 1: EMPIRE STATE BUILDING
STREET 2: 350 5TH AVENUE, SUITE 5330
CITY: NEW YORK
STATE: NY
ZIP: 10118
FORMER COMPANY:
FORMER CONFORMED NAME: Incysus Therapeutics, Inc.
DATE OF NAME CHANGE: 20180510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-01
0
0001740279
IN8BIO, INC.
INAB
0001853815
Greenwood Luba
C/O IN8BIO, INC.
350 5TH AVE. SUITE 5330
NEW YORK
NY
10118
1
0
0
0
Stock Option (right to buy)
2.24
2022-06-01
4
A
0
10500
0.00
A
2032-06-01
Common Stock
10500
10500
D
One twelfth (1/12th) of the shares subject to the option shall vest in equal monthly installments commencing on July 1, 2022 and will be fully vested on the date of the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide service through each such date.
/s/ Jason Minio, Attorney-in-Fact
2022-06-14